Drug Discovery

Can Novo Nordisk's Semaglutide Treat Metabolic Liver Disease MASH?
Research & Development Can Novo Nordisk's Semaglutide Treat Metabolic Liver Disease MASH?

Novo Nordisk recently announced its intention to seek regulatory approval for the use of semaglutide, the active ingredient in its profitable weight loss drug, for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). This decision came after a Phase 3 clinical trial yielded

Denmark's First AI Supercomputer Gefion Launched to Propel Innovation
Research & Development Denmark's First AI Supercomputer Gefion Launched to Propel Innovation

In a landmark event for Denmark’s technology landscape, the nation's first AI supercomputer, Gefion, has been officially inaugurated. This momentous occasion promises to expedite drug discovery and address a variety of societal challenges. The Novo Nordisk Foundation, a principal player in the

How Will AI Transform Drug Discovery and Development in Biopharma?
Research & Development How Will AI Transform Drug Discovery and Development in Biopharma?

Artificial Intelligence (AI) has the potential to revolutionize drug discovery and development, offering numerous advantages that could transform current practices in the biopharmaceutical industry. By merging Accenture's advanced capabilities in AI scaling with the innovative ITO™ platform d

Ryvu and nCage Partner to Innovate Antibody-Drug Conjugate Therapies
Research & Development Ryvu and nCage Partner to Innovate Antibody-Drug Conjugate Therapies

In a pioneering move to advance cancer treatment, Ryvu Therapeutics and nCage Therapeutics have announced a research collaboration aimed at developing a next-generation antibody-drug conjugate (ADC) platform. This partnership promises to leverage nCage's TRAP cage platform, a novel drug

How Does ROXYBOND Fight Opioid Abuse and Ensure Pain Relief?
Research & Development How Does ROXYBOND Fight Opioid Abuse and Ensure Pain Relief?

The recent FDA approval of Protega Pharmaceuticals Inc.'s ROXYBOND (oxycodone hydrochloride) immediate-release (IR) CII 10 mg tablet marks a significant milestone in managing severe pain where alternative treatments fall short. ROXYBOND 10 mg stands out as the first FDA-approved

How Will Kapoose Creek Bio's New Acquisition Transform Drug Discovery?
Research & Development How Will Kapoose Creek Bio's New Acquisition Transform Drug Discovery?

Kapoose Creek Bio, a biotechnology firm well-versed in AI-driven natural product drug discovery, has made a significant leap forward with its latest acquisition. The company has secured an exclusive license to the chemical informatics platform of Adapsyn Bioscience and acquired Adapsyn's drug

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later